Literature DB >> 20587514

Mouse models for the p53 R72P polymorphism mimic human phenotypes.

Feng Zhu1, Martijn E T Dollé, Thomas R Berton, Raoul V Kuiper, Carrie Capps, Alexsandra Espejo, Mark J McArthur, Mark T Bedford, Harry van Steeg, Annemieke de Vries, David G Johnson.   

Abstract

The p53 tumor suppressor gene contains a common single nucleotide polymorphism (SNP) that results in either an arginine or proline at position 72 of the p53 protein. This polymorphism affects the apoptotic activity of p53 but the mechanistic basis and physiologic relevance of this phenotypic difference remain unclear. Here, we describe the development of mouse models for the p53 R72P SNP using two different approaches. In both sets of models, the human or humanized p53 proteins are functional as evidenced by the transcriptional induction of p53 target genes in response to DNA damage and the suppression of early lymphomagenesis. Consistent with in vitro studies, mice expressing the 72R variant protein (p53R) have a greater apoptotic response to several stimuli compared with mice expressing the p53P variant. Molecular studies suggest that both transcriptional and nontranscriptional mechanisms may contribute to the differential abilities of the p53 variants to induce apoptosis. Despite a difference in the acute response to UV radiation, no difference in the tumorigenic response to chronic UV exposure was observed between the polymorphic mouse models. These findings suggest that under at least some conditions, the modulation of apoptosis by the R72P polymorphism does not affect the process of carcinogenesis. (c)2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20587514      PMCID: PMC2905499          DOI: 10.1158/0008-5472.CAN-09-4646

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  The p53 codon 72 polymorphism, sunburns, and risk of skin cancer in US Caucasian women.

Authors:  Jiali Han; David G Cox; Graham A Colditz; David J Hunter
Journal:  Mol Carcinog       Date:  2006-09       Impact factor: 4.784

2.  Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation.

Authors:  Thomas R Berton; David L Mitchell; Ruifeng Guo; David G Johnson
Journal:  Oncogene       Date:  2005-04-07       Impact factor: 9.867

3.  The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.

Authors:  M A Christophorou; I Ringshausen; A J Finch; L Brown Swigart; G I Evan
Journal:  Nature       Date:  2006-09-06       Impact factor: 49.962

4.  The codon 72 polymorphism-specific effects of human p53 are absent in mouse cells: implications on generation of mouse models.

Authors:  B H Phang; K Sabapathy
Journal:  Oncogene       Date:  2006-11-20       Impact factor: 9.867

5.  A genetic variant BDNF polymorphism alters extinction learning in both mouse and human.

Authors:  Fatima Soliman; Charles E Glatt; Kevin G Bath; Liat Levita; Rebecca M Jones; Siobhan S Pattwell; Deqiang Jing; Nim Tottenham; Dima Amso; Leah H Somerville; Henning U Voss; Gary Glover; Douglas J Ballon; Conor Liston; Theresa Teslovich; Tracey Van Kempen; Francis S Lee; B J Casey
Journal:  Science       Date:  2010-01-14       Impact factor: 47.728

6.  Tumor susceptibility and apoptosis defect in a mouse strain expressing a human p53 transgene.

Authors:  Crissy Dudgeon; Calvina Kek; Oleg N Demidov; Shin-ichi Saito; Kenneth Fernandes; Alexandra Diot; Jean-Christophe Bourdon; David P Lane; Ettore Appella; Albert J Fornace; Dmitry V Bulavin
Journal:  Cancer Res       Date:  2006-03-15       Impact factor: 12.701

7.  A single nucleotide change in the mouse genome accelerates breast cancer progression.

Authors:  Nina Seitzer; Thomas Mayr; Sylvia Streit; Axel Ullrich
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

8.  Dominant-negative but not gain-of-function effects of a p53.R270H mutation in mouse epithelium tissue after DNA damage.

Authors:  Susan W P Wijnhoven; Ewoud N Speksnijder; Xiaoling Liu; Edwin Zwart; Conny Th M vanOostrom; Rudolf B Beems; Esther M Hoogervorst; Mirjam M Schaap; Laura D Attardi; Tyler Jacks; Harry van Steeg; Jos Jonkers; Annemieke de Vries
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

Review 9.  p53 polymorphisms: cancer implications.

Authors:  Catherine Whibley; Paul D P Pharoah; Monica Hollstein
Journal:  Nat Rev Cancer       Date:  2009-02       Impact factor: 60.716

10.  iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.

Authors:  Daniele Bergamaschi; Yardena Samuels; Alexandra Sullivan; Marketa Zvelebil; Hilde Breyssens; Andrea Bisso; Giannino Del Sal; Nelofer Syed; Paul Smith; Milena Gasco; Tim Crook; Xin Lu
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

View more
  30 in total

1.  The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the Liver.

Authors:  Julia I-Ju Leu; Maureen E Murphy; Donna L George
Journal:  J Liver       Date:  2013

Review 2.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

3.  Tissue-specific apoptotic effects of the p53 codon 72 polymorphism in a mouse model.

Authors:  Gregory A Azzam; Amanda K Frank; Monica Hollstein; Maureen E Murphy
Journal:  Cell Cycle       Date:  2011-05-01       Impact factor: 4.534

4.  Study on the association of p53 codon 72 polymorphisms with risk of gastric cancer in high incidence Hexi area of Gansu Province in China.

Authors:  Zhu Ke-Xiang; Li Yu-Min; Li Xun; Zhou Wen-Ce; Shan Yong; Liu Tao
Journal:  Mol Biol Rep       Date:  2011-05-12       Impact factor: 2.316

5.  Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time.

Authors:  Erwin Reiling; Valeriya Lyssenko; Jolanda M A Boer; Sandra Imholz; W Monique M Verschuren; Bo Isomaa; Tiinamaija Tuomi; Leif Groop; Martijn E T Dollé
Journal:  Eur J Hum Genet       Date:  2011-12-21       Impact factor: 4.246

6.  An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk.

Authors:  Kui-Jie Liu; Hai-Zhi Qi; Hong-Liang Yao; San-Lin Lei; Zhen-Dong Lei; Tie-Gang Li; Hua Zhao
Journal:  Mol Biol Rep       Date:  2012-06-16       Impact factor: 2.316

7.  The Roles of P53 and Its Family Proteins, P63 and P73, in the DNA Damage Stress Response in Organogenesis-Stage Mouse Embryos.

Authors:  Nazem El Husseini; Barbara F Hales
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

Review 8.  Illuminating p53 function in cancer with genetically engineered mouse models.

Authors:  Patty B Garcia; Laura D Attardi
Journal:  Semin Cell Dev Biol       Date:  2014-01-03       Impact factor: 7.727

9.  The p53 R72P polymorphism does not affect the physiological response to ionizing radiation in a mouse model.

Authors:  Emily R Domínguez; Jennifer Orona; Kevin Lin; Carlos J Pérez; Fernando Benavides; Donna F Kusewitt; David G Johnson
Journal:  Cell Cycle       Date:  2017-06-08       Impact factor: 4.534

10.  Modeling gene-environment interactions in oral cavity and esophageal cancers demonstrates a role for the p53 R72P polymorphism in modulating susceptibility.

Authors:  Jayanta Sarkar; Emily Dominguez; Guojun Li; Donna F Kusewitt; David G Johnson
Journal:  Mol Carcinog       Date:  2013-03-08       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.